Rivaroxaban Viatris 10 mg

Rivaroxaban Viatris 10 mg is a medicine authorised by Swissmedic under authorisation number 69319. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 October 2023 and the authorisation is limited until 18 October 2028. ATC code B01AF01 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 69319
  • ATC B01AF01
  • Synthetic medicines
Authorisation data
Authorisation number69319
NameRivaroxaban Viatris 10 mg
Full nameRivaroxaban Viatris 10 mg, Filmtabletten
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AF01
First authorisation19 October 2023
Authorisation validity18 October 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Rivaroxaban Viatris 10 mg, FilmtablettenB19 October 2023
2Rivaroxaban Viatris 15 mg, FilmtablettenB19 October 2023
3Rivaroxaban Viatris 20 mg, FilmtablettenB19 October 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)B01AF0106.03.0.B
230Tablette(n)B01AF0106.03.0.B
398Tablette(n)B01AF0106.03.0.B
414Tablette(n)B01AF0106.03.0.B
528Tablette(n)B01AF0106.03.0.B
698Tablette(n)B01AF0106.03.0.B
714Tablette(n)B01AF0106.03.0.B
828Tablette(n)B01AF0106.03.0.B
998Tablette(n)B01AF0106.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivaroxaban Viatris 10 mg authorised in Switzerland?

Yes. Rivaroxaban Viatris 10 mg is authorised by Swissmedic under authorisation number 69319, data as of 01 September 2026. The authorisation is limited until 18 October 2028.

Which dispensing category does Rivaroxaban Viatris 10 mg have?

Rivaroxaban Viatris 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivaroxaban Viatris 10 mg?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com